Home›Anesthesiology & Pain Medicine› Thermal RFA reduces pain more than steroid injections in facet joint syndrome, but effect may not be clinically meaningful
Thermal RFA reduces pain more than steroid injections in facet joint syndrome, but effect may not be clinically meaningfulThermal Radiofrequency Ablation Shows Better Pain Relief Than Injections
Pain managementPublished August 4, 2026Study authors: Le Justin, Liu Han Jie, Atschinow Andrew, Huang Lisa, Tran Jason, Rana Anish, Lazar Brandon, Siu Gil…PubMed ↗DOI ↗Editorial oversight: Dr. Ji-eun Park, MD · Brain, Mind & Pain
AI-generated summary of the cited source, checked by automated accuracy review.
How we work
Share
Key Takeaway
Consider thermal RFA for facet joint syndrome, but note the pain reduction may not be clinically meaningful.
This meta-analysis pooled data from 146 patients with facet-mediated chronic low back pain to compare thermal radiofrequency ablation (RFA) with corticosteroid injections. The primary outcome was pain reduction measured by the Visual Analog Scale (VAS) at 3 and 6 months. At 3 months, RFA was associated with significantly greater pain reduction (mean difference [MD] = -1.27; 95% CI, -1.96 to -0.58; p = 0.0003). At 6 months, the benefit persisted (MD = -0.86; 95% CI, -1.18 to -0.54; p < 0.00001).
However, the authors noted that the observed differences fell underneath the minimally important clinical difference (MCID), meaning that while statistically significant, the improvement may not be perceptible to patients. This is a critical caveat when interpreting the results.
The meta-analysis did not report adverse events, serious adverse events, or discontinuations, so the safety profile of RFA relative to corticosteroid injections could not be assessed. Additionally, the study did not report funding or conflicts of interest.
Given the modest effect size and lack of safety data, clinicians should interpret these findings cautiously. Thermal RFA may offer a short-term advantage in pain reduction over corticosteroid injections, but the clinical significance remains uncertain. Further research is needed to determine whether this difference translates into meaningful patient outcomes.
How this fits prior evidence
This meta-analysis extends prior evidence on interventional pain management by directly comparing thermal RFA to corticosteroid injections for facet joint syndrome. It confirms that RFA can provide statistically greater pain reduction, but the effect size is small and may not reach clinical significance. This contrasts with prior coverage on oral propranolol for infantile hemangioma, where a clear first-line therapy was identified; here, the advantage of RFA is less definitive. The findings also highlight the importance of considering MCID, a concept not addressed in the prior items.
Researchers analyzed data from 146 patients with chronic low back pain caused by facet joint syndrome. They compared two different treatments: corticosteroid injections and a procedure called thermal radiofrequency ablation (RFA). The goal was to see which method provided better relief over a six-month period.
The results showed that patients who received the RFA treatment experienced significantly greater reductions in pain at both three months and six months compared to those who received steroid injections. While the difference was statistically significant, it is important to note that the improvement did not reach the threshold for what experts call a minimally important clinical difference. This means the gap between the two treatments might be small in daily practice.
Because this study involved a small number of patients and the results were modest, these findings should be viewed as preliminary. The research suggests RFA may have a slight advantage for short-term pain relief, but it does not prove it is a superior treatment for everyone. Patients should discuss these options with their doctor to see if RFA is appropriate for their specific condition.
What this means for you:
RFA showed greater pain reduction than steroid injections, though the difference was modest in clinical practice.
Common questions
How does RFA compare to steroid injections for back pain?
The study found that thermal radiofrequency ablation (RFA) resulted in significantly greater pain reduction at both 3 months and 6 months compared to corticosteroid injections. However, the difference between the two treatments was noted as falling below the threshold for a minimally important clinical difference.
Is RFA more effective than steroids for facet joint syndrome?
The analysis of 146 patients showed that RFA provided better pain reduction than steroid injections for those with facet-mediated chronic low back pain. While the results were statistically significant, the actual difference in daily experience may be modest.
What are the risks of these treatments?
The data provided did not report specific adverse events, serious complications, or issues with tolerability for either treatment. You should speak with your doctor to discuss the specific safety profile and risks of RFA versus steroid injections for your condition.
BACKGROUND: Facet joint syndrome (FJS) is a prevalent cause of chronic low back pain (CLBP), resulting in reduced quality of life. Radiofrequency ablation (RFA) and corticosteroid injections are commonly utilized; however, direct comparative evidence specific to lumbar FJS remains limited.
METHODS: A comprehensive search of PubMed, Embase, Web of Science, Cochrane Library, and Scopus (from inception to November 2025) was conducted to identify randomized controlled trials (RCTs) evaluating thermal RFA versus corticosteroid injections. The primary outcome measured was the Visual Analog Scale (VAS) at 3- and 6-months. Review Manager 5.4 was used to evaluate mean differences (MD) across outcomes using a random-effects model.
RESULT: Three RCTs with a total of 146 patients were included. Pooled analysis demonstrated significantly greater pain reduction with RFA at both 3-months (MD = -1.27; 95% CI, -1.96 to -0.58; = 0.0003) and 6-months (MD = -0.86; 95% CI, -1.18 to -0.54; < 0.00001), favoring RFA. Heterogeneity was moderate to low across timepoints. Although significant, these results fell underneath the minimally important clinical difference (MCID).
CONCLUSION: In our study, thermal RFA provided greater pain reduction than corticosteroid injections for FJS causing CLBP, suggesting a modest short-term advantage in pain reduction.
